All Stories

  1. Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: a systematic review and meta-analysis
  2. Targeted radionuclide therapy directed to the tumor phenotypes: A dosimetric approach using MC simulations
  3. An Optimized Methodology for Patient-Specific Therapeutic Activity Administration in Liver Radioembolization
  4. Patlak plot based on the first 30 minutes post-injection dynamic 18F-florbetaben positron emission tomography scan separates amyloid-β positive from negative studies
  5. Brain [18F]Fluorodeoxyglucose Metabolism Assessment under Hypothyroidism and Recombinant Human Thyroid-Stimulating Hormone in Comparison with Thyroid Hormone Replacement in Patients Submitted to Total Thyroidectomy
  6. Positron Emission Tomography–Derived Metrics Predict the Probability of Local Relapse After Oligometastasis-Directed Ablative Radiation Therapy
  7. Las relaciones de ventilación/perfusión corregidas por píxeles mejoraron la detección de defectos de perfusión no coincidentes
  8. PSMA expression in thyroid nodule
  9. 123I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease: a new quantitative analysis of autopsy confirmed cases
  10. Are lesion features reproducible between 18F-FDG PET/CT images when acquired on analog or digital PET/CT scanners?
  11. Asymptomatic COVID-19 positive patient suspected on FDG-PET/CT
  12. Negative affect and stress‐related brain metabolism in patients with metastatic breast cancer
  13. Principles and Constraints of Nonrigid Registration
  14. Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients
  15. Phenotype-Oriented Ablation of Oligometastatic Cancer with Single Dose Radiation Therapy
  16. Using 3D anthropometric data for the modelling of customised head immobilisation masks
  17. Segmentation of pathological liver tissue with Dilated Fully Convolutional Networks: A Preliminary Study
  18. Evaluation of the attenuation correction on myocardial perfusion imaging: a phantom study
  19. Voxel-Based Computational Tools Help Liver Dosimetry Calculations of Multiple (External and Internal) Radiation Therapies
  20. Gastric GIST Incidentally Detected on 68Ga-PSMA-PET/CT
  21. Comparison of the 90Y-labelled glass microspheres liver radioembolisation dosimetry with the estimated dosimetry obtained from pre-treatment 99mTc-MAA SPECT images reconstructed with and without attenuation correction
  22. Radiopharmacology and molecular imaging of PD-L1 expression in cancer
  23. Patient-specific gamma-index analysis to evaluate 99mTc-MAA as a predictor for 90Y glass microspheres liver radioembolisation dosimetry
  24. Activity estimation and biokinetic analysis of 99mTc-DMSA in renal infant patients using a gamma camera
  25. Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123I]FP-CIT SPECT images
  26. Radioembolization with 90Y-Labeled Glass Microspheres: Analytical Methods for Patient-Personalized Voxel-Based Dosimetry
  27. The Importance of SPECT Imaging Attenuation Correction During Treatment Planning for 90Y-labeled Glass Microspheres Liver Radioembolization
  28. 18F-FDG Uptake in Ischemic Colitis During Follow-up of a Patient With Lung Cancer
  29. Gamma-index and dose-volume histograms (based on voxel dosimetry) to evaluate the predictive power of 99mTc-MAA SPECT maps in comparison with post-radioembolization 90Y PET maps
  30. Nuclear Medicine in Oncology
  31. Effect of reconstruction processing methods and analysis in the quantification of brain spect studies with DaTSCAN™
  32. Optimization of activity and absorbed doses calculation to target/tumor and normal liver volumes in patients submitted to yttrium-90 radioembolization with glass microspheres
  33. Nuclear medicine training in the European Union: 2015 update
  34. The influence of number of counts in the myocardium in the determination of reproducible functional parameters in gated-SPECT studies simulated with GATE
  35. Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS)
  36. Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages
  37. Analysis of gated myocardial perfusion spect images based on computational image registration
  38. Estimation of the collective ionizing dose in the Portuguese population for the years 2011 and 2012, due to nuclear medicine exams
  39. Ideas from the second UEMS conference on CME/CPD: new EU directives on a patients’ rights in cross-border healthcare and professional qualifications
  40. Individual-Reader Diagnostic Performance and Between-Reader Agreement in Assessment of Subjects with Parkinsonian Syndrome or Dementia Using 123I-Ioflupane Injection (DaTscan) Imaging
  41. FDG gated cardiac PET at rest and immediately after dobutamine stress
  42. Monte Carlo simulation of the basic features of the GE Millennium MG single photon emission computed tomography gamma camera
  43. The new UEMS-EACCME criteria for accreditation of live educational events (LEEs): another step forward to improve the quality of continuing medical education (CME) in Europe
  44. Phenotypes of myocardial blood perfusion related to the genetic variations of metalloproteinases 3 (MMP3) and 9 (MMP9)
  45. Texton-based diagnosis of Alzheimer's disease
  46. Image quality of myocardial perfusion-gated studies: effect of ingestion of different fat content in the reduction of extra-myocardial abdominal signal
  47. Left ventricular function influenced byMMP3gene 5A/6A polymorphism (rs3025058): a gated-SPECT study
  48. Continuing Medical Education Committee and UEMS-EACCME
  49. UEMS/EBNM endeavour – celebrations keep going!
  50. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT
  51. 3D brain image-based diagnosis of Alzheimer's disease: Bringing medical vision into feature selection
  52. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson’s disease?
  53. Syllabus for Postgraduate Specialization in Nuclear Medicine – 2011/2012 Update
  54. UEMS/EBNM endeavour
  55. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECT
  56. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy
  57. [123I] FP‐CIT spect study in vascular parkinsonism and Parkinson's disease
  58. Applications of PET–CT in clinical practice: Present and future
  59. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
  60. Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner
  61. Parkinsonism due to Kernohan notch: Clinical, structural, and functional imaging correlates
  62. Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18 FDG and 18 FLT PET
  63. L‐dopa–responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings
  64. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease
  65. Clinical audit in nuclear medicine
  66. Comparison of methodologies for the in vivo assessment of 18 FLT utilisation in colorectal cancer
  67. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP‐CIT/SPECT study
  68. Frontal lobe dysfunction in sporadic hyperekplexia
  69. In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography
  70. Dementia with Lewy bodies versus Alzheimer's disease: Role of dopamine transporter imaging
  71. Potential impact of [ 18 F]3'-deoxy-3'-fluorothymidine versus [ 18 F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer
  72. Positron emission and computed X-ray tomography: a coming together
  73. [123I]‐FP‐CIT‐SPECT demonstrates dopaminergic deficit in orthostatic tremor
  74. In vivo Dopamine Pre-Synaptic Receptors and Antioxidant Activities in Patients with Alzheimer’s Disease, Dementia with Lewy Bodies and in Controls
  75. [ 123 I]-FP-CIT-SPECT in the early diagnosis of PD presenting as exercise-induced dystonia
  76. CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET
  77. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study
  78. Fluorodeoxyglucose positron emission tomography in clinical oncology: the referrerʼs perspective
  79. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand
  80. Nuclear Medicine in Primary Breast Cancer Imaging
  81. Typical antipsychotic drugs — D2 receptor occupancy and depressive symptoms in schizophrenia
  82. Can ROI methodology/normalised tissue activities be used instead of absolute blood flow measurements in the brain?
  83. Glucose Utilisation and Cell Proliferation in Colorectal Cancer
  84. Dopamine neurotransmission, Parkinson’s disease and SPET
  85. The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders
  86. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer
  87. Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F]FDG PET
  88. PET e SPECT em neurologia e psiquiatria: do básico às aplicações clínicas
  89. Functional imaging of malignant paragangliomas and carcinoid tumours
  90. Clinical role of positron emission tomography in oncology
  91. Functional imaging as an aid to decision-making in metastatic paraganglioma
  92. Asymptomatic patient with an increasing concentration of CEA
  93. Positron emission tomography and colorectal cancer
  94. SPECT imaging of the dopamine transporter in juvenile-onset dystonia
  95. A SPECT study of the effect of vagal nerve stimulation on thalamic activity in patients with epilepsy
  96. Levels of γ‐Aminobutyric Acid‐Benzodiazepine Receptors in Abstinent, Alcohol‐Dependent Women: Preliminary Findings From an 123I‐Iomazenil Single Photon Emission Tomography Study
  97. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group
  98. Patterns of brain activity in patients with epilepsy and depression
  99. Nuclear medicine in neurology and psychiatry
  100. In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies
  101. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine
  102. Crisis after angiography: time for MIBG
  103. 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine
  104. Early detection of melanoma metastases with radioiodinated methylene blue
  105. Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS.
  106. Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy
  107. Cognitive functioning and GABAA/benzodiazepine receptor binding in schizophrenia: A 1231-iomazenil SPET study
  108. Recurrent follicular carcinoma-oxyphilic cell type (Hürthle cell carcinoma) of the thyroid, imaging with iodine-131 and technetium-99m tetrofosmin before and after radiotherapy.
  109. Relationship Between SPECT Scans and Buspirone Tests in Patients with ME/CFS
  110. Wisconsin Card Sorting Task (WCST) errors and cerebral blood flow in obsessive‐compulsive disorder (OCD)
  111. Brain blood flow in anxiety disorders
  112. Serotonin: 5-HT2A receptor occupancy in vivo and response to the new antipsychotics olanzapine and sertindole
  113. Limbic selectivity of clozapine
  114. Dementia with Lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography
  115. Dementia with Lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon mission tomography
  116. Initial evaluation of123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects
  117. HMPAO SPET does not distinguish obsessive–compulsive and tic syndromes in families multiply affected with Gilles de la Tourette's syndrome
  118. Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy.
  119. Thrombosis and restenosis after peripheral angioplasty: Does acute 111indium-platelet accumulation predict angioplasty outcome?
  120. In vivo effects on striatal dopamine D 2 receptor binding by the novel atypical antipsychotic drug sertindole - a 123 I IBZM single photon emission tomography (SPET) study
  121. Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography
  122. Initial evaluation of123|-5-|-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects
  123. Multivariate cluster analysis of dynamic iodine-123 iodobenzamide SPET dopamine D2 receptor images in schizophrenia
  124. 5-HT2A receptor blockade in vivo in schizophrenic patients treated with atypical antipsychotics: Single photon emission tomography (SPET) findings
  125. Multivariate cluster analysis of dynamic [I-123]-IBZM spet dopamine D2 receptor images in schizophrenia
  126. Non-invasive measurement of left ventricular volumes and function by gated positron emission tomography
  127. HMPAO SPECT in non-epileptic seizures: preliminary results
  128. The significance of increased 111indium platelet accumulation at post-angioplasty sites
  129. Polycythaemia and agoraphobia
  130. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine — a123 IBZM single photon emission tomography (SPET) study
  131. Pathophysiology of Chronic Left Ventricular Dysfunction
  132. Baseline Left Ventricular (LV) performance and functional recovery after revascularisation: Predictive value of absolute 18F Fluorodeoxyglucose (FDG) uptake
  133. Brainstem perfusion is impaired in chronic fatigue syndrome
  134. Regional Cerebral Blood Flow in Obsessive-Compulsive Disordered Patients at Rest
  135. Schizophrenic auditory hallucinations are associated with increased regional cerebral blood flow during verbal memory activation in a study using single photon emission computed tomography
  136. Immunoscintigraphy with a 99Tcm-labelled anti-granulcyte monoclonal antibody in patients with human immunodeficiency virus infection and AIDS
  137. Technetium-99m-L,L-ethylenedicysteine scintigraphy in patients with renal disorders
  138. Optimised interictal HMPAO-SPECT in the evaluation of partial epilepsies
  139. Clinical brain radionuclide imaging studies
  140. Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls
  141. Differentiation between Alzheimer's disease and multi‐infarct dementia: Spect vs MR imaging
  142. Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride — an123I-IBZM single photon emission tomography (SPET) study
  143. In vivo imaging of GABAA receptors using sequential whole-volume iodine-123 iomazenil single-photon emission tomography
  144. Dopamine receptor availability in Tourette's syndrome
  145. Clinical experience with a multidetector SPET system (Toshiba GCA-9300A)
  146. Chronic fatigue syndrome Role of psychological factors overemphasised
  147. Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia
  148. HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness.
  149. D2 Dopamine Receptor Binding in the Basal Ganglia of Antipsychotic-Free Schizophrenic Patients
  150. Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone
  151. 99mTc-HMPAO single photon emission tomography in late life depression: a pilot study of regional cerebral blood flow at rest and during a verbal fluency task
  152. Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study
  153. Elevated frontal cerebral blood flow in Gilles de la Tourette syndrome: A 99Tcm-HMPAO SPECT study
  154. Assessment of myocardial viability with 201T1 SPET and reinjection technique
  155. Demonstration of human motor cortex activation using SPECT
  156. Effect of vigabatrin on striatal dopamine receptors: evidence in humans for interactions of GABA and dopamine systems.
  157. rCBF abnormalities detected, and sequentially followed, by SPECT in neuro-Behcet's syndrome with normal CT and MRI imaging
  158. Cerebral Blood Flow Abnormalities in Adults with Infantile Autism
  159. Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia
  160. Vasodilator myocardial perfusion imaging: demonstration of local electrophysiological changes of ischaemia
  161. Postviral fatigue syndrome.
  162. SPECT in epilepsy
  163. Physical assessment of the GE/CGR Neurocam and comparison with a single rotating gamma-camera
  164. Diagnosing Alzheimer's disease.
  165. Thallium Myocardial Perfusion Tomography in Clinical Cardiology
  166. Clinical Applications
  167. Clinical Case Material
  168. Image Interpretation
  169. Introduction
  170. Radiopharmaceuticals
  171. Stress Techniques
  172. The Future
  173. Endocardial monophasic action potential recordings for the detection of muocardial ischemia in man: A study using atrial pacing stress and myocardial perfusion scintigraphy
  174. Single photon emission tomography in Alzheimer's disease. A longitudinal study of changes in relative regional cerebral blood flow
  175. Single photon emission tomography in growth-hormone related Creutzfeldt-Jakob disease
  176. Diagnosis of brain death with technetium 99m hexamethylpropylene amine oxime
  177. The use of cerebral activation procedures with single photon emission tomography
  178. 99TCm-HMPAO SPECT studies in traumatic intracerebral haematoma.
  179. A Historical and Philosophical Review of Localizing Brain Function
  180. Activation Protocols in Normal Subjects Using SPET: A Window into Normal Brain Function
  181. Activation Studies in Specific Disease States: Future Applications
  182. Clinical Use of SPET Imaging in Psychiatric and Neurological Disease
  183. Description and Principles of Neuroactivation
  184. Models of Brain Processing with Respect to Functional Neuroimaging
  185. Neuroactivation and Neuroimaging with SPET
  186. Principles of Emission Tomography
  187. Radiopharmaceutical Ligands and Tracers
  188. Review of Previous SPET Neuroactivation Studies in Normal Controls
  189. SPET Instrumentation: Characteristics and New Developments
  190. The use of cerebral activation procedures with single photon emission tomography
  191. In vivo characterisation of 3-iodo-6-methoxybenzamide123I in humans
  192. Single photon emission tomography (SPET) with 99Tc m-hexamethylpropyleneamineoxime (HMPAO) in research and clinical practice - a useful tool
  193. Regional cerebral blood flow (rCBF) during migraine using 99mTc-hexamethylpropyleneamineoxime (99mTc-HMPAO) and single photon emission tomography (SPET)
  194. 99Tcm-HMPAO SPET and cerebral blood flow
  195. Intracellular localization of 99Tcm-d, 1-HMPAO and 201T1-DDC in rat brain
  196. DIAGNOSIS OF HERPES SIMPLEX ENCEPHALITIS BY SINGLE PHOTON EMISSION TOMOGRAPHY
  197. ROLE OF ROUTINE FUNCTIONAL BRAIN IMAGING IN TEMPORAL LOBE EPILEPSY
  198. 99mTc-HMPAO WASHOUT FROM BRAIN
  199. Technetium-99m Pentavalent DMSA Imaging Detects Metastases of Poorly Differentiated Carcinoma of the Thyroid
  200. The investigation of Alzheimer's disease with single photon emission tomography.
  201. 99mTc-HMPAO WASHOUT IN PROGNOSIS OF STROKE
  202. White cells radiolabelled with 111IN AND 99Tcm- a study of relative sensitivity and in vivo viability
  203. RADIONUCLIDE IMAGING OF SCROTUM
  204. TRANSIENT LEUCOPENIA INDUCED BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
  205. IMAGING CEREBRAL DAMAGE IN HIV INFECTION
  206. Functional imaging of the brain
  207. Stress induced right ventricular dysfunction: An indication of reversible right ventricular ischaemia
  208. The in vivo distribution of 99Tcm-HM-PAO in normal man
  209. REGULAR CEREBRAL BLOOD FLOW MAPPING WITH 99mTc-LABELLED COMPOUND